Phase 2 Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing and able to sign a consent form agreeing to take part in the study.
- You are willing to follow all study procedures and can participate for the full length of the study.
- You are male or female, between 11 and 25 years old.
- You have been diagnosed with Crohn's Disease or Ulcerative Colitis.
- Your condition is currently in remission (not actively flaring), as measured by specific scoring tools based on your age and diagnosis (confirm with trial site).
- You are not currently taking corticosteroid medications (such as prednisone).
- You have been on a stable dose of adalimumab, infliximab, or infliximab-dyyb for at least 12 weeks before joining the study.
- If you take mesalamine, mercaptopurine, azathioprine, or methotrexate, your dose has been stable for at least 12 weeks before joining.
- You agree not to make major changes to your diet during the study, such as switching to a vegan, Specific Carbohydrate Diet, or exclusive liquid nutrition diet.
- If you have Crohn's Disease and had one bowel resection surgery involving only a limited part of the colon, and it was at least six months ago, you may still be eligible (confirm with trial site).
Who may not be able to join:
- You have had an active flare-up of your IBD in the past six months.
- You have used antibiotics, probiotics, or prebiotics in the past month.
- You have been diagnosed with celiac disease, diabetes, or another condition that the study doctor determines makes participation unsafe.
- You have taken part in another clinical trial or received an experimental treatment in the past 4 weeks.
- You have received another biologic medication for IBD in the past 12 weeks.
- You have difficulty digesting lactose (lactose intolerance).
- You are currently pregnant or breastfeeding.
- You have had more than one IBD-related surgery, or a surgery removing most of your colon (if you have Crohn's Disease), or any colonic surgery (if you have Ulcerative Colitis).
- You are currently using anti-diarrheal medications.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-(513)-636-1412
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Mean Gastrointestinal Symptom Rating Scale (GSRS) in participants who receive 2'-fucosyllactose (2'FL) or dextrose placebo
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.